Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Nephrology
•
End stage kidney disease
Do you recommend avoiding ESAs in pregnant patients with anemia of chronic kidney disease who also have preeclampsia?
Answer from: at Academic Institution
Yes
Sign in or Register to read more
23744
Related Questions
What is your preferred fill volume, dialysis solution, and dwell time for patients with suspected peritoneal dialysis associated peritonitis who arrive to the hospital with a dry abdomen?
How would you manage an ESKD patient who complains of severe fatigue after hemodialysis, but does not experience intradialytic or post-dialysis hypotension and has not responded to dry weight adjustments?
How do you adjust your management strategy to address the unique needs of anuric end-stage kidney disease patients when treating diabetic ketoacidosis?
Do you increase the frequency of hemodialysis for patients with calciphylaxis?
Do you avoid ESAs in patients with end stage kidney disease who also have heart failure due to increased risk of stroke?
Would you consider treating hypercalcemia with CRRT and regional citrate anticoagulation for a dialysis dependent patient who does not respond to bisphosphonate therapy and low calcium dialysate bath?
Should GLP1 R agonists be used as first line glucose lowering agents in patients with ESKD and DM2?
What is your approach to management of intradialytic hypotension and autonomic dysfunction in a patient with ESKD?
How do you approach the management of persistent hyperphosphatemia in ESKD patients who are non-adherent to phosphate binders?
How often do you recommend basic metabolic panel checks in a hospitalized ESKD patient on thrice weekly hemodialysis and for whom hyperkalemia is not of major concern?